These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8103145)
1. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Sung JJ; Chung SC; Lai CW; Chan FK; Leung JW; Yung MY; Kassianides C; Li AK Lancet; 1993 Sep; 342(8872):637-41. PubMed ID: 8103145 [TBL] [Abstract][Full Text] [Related]
2. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Jenkins SA; Shields R; Davies M; Elias E; Turnbull AJ; Bassendine MF; James OF; Iredale JP; Vyas SK; Arthur MJ; Kingsnorth AN; Sutton R Gut; 1997 Oct; 41(4):526-33. PubMed ID: 9391254 [TBL] [Abstract][Full Text] [Related]
3. Sclerotherapy with or without octreotide for acute variceal bleeding. Besson I; Ingrand P; Person B; Boutroux D; Heresbach D; Bernard P; Hochain P; Larricq J; Gourlaouen A; Ribard D N Engl J Med; 1995 Aug; 333(9):555-60. PubMed ID: 7623904 [TBL] [Abstract][Full Text] [Related]
4. Octreotide in the control of post-sclerotherapy bleeding from oesophageal varices, ulcers and oesophagitis. Jenkins SA; Kingsnorth AN; Ellenbogen S; Copeland G; Davies N; Sutton R; Shields R HPB Surg; 1996; 10(1):1-6. PubMed ID: 9187545 [TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding. Sivri B; Oksuzoglu G; Bayraktar Y; Kayhan B Hepatogastroenterology; 2000; 47(31):168-73. PubMed ID: 10690604 [TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro-oesophageal variceal hemorrhage. Shah HA; Mumtaz K; Jafri W; Abid S; Hamid S; Ahmad A; Abbas Z J Ayub Med Coll Abbottabad; 2005; 17(1):10-4. PubMed ID: 15929518 [TBL] [Abstract][Full Text] [Related]
7. Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate. Sung JJ; Yeo W; Suen R; Lee YT; Chung SC; Chan FK; Johnson PJ Gastrointest Endosc; 1998 Mar; 47(3):235-9. PubMed ID: 9540875 [TBL] [Abstract][Full Text] [Related]
8. A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. Shields R; Jenkins SA; Baxter JN; Kingsnorth AN; Ellenbogen S; Makin CA; Gilmore I; Morris AI; Ashby D; West CR J Hepatol; 1992 Sep; 16(1-2):128-37. PubMed ID: 1362432 [TBL] [Abstract][Full Text] [Related]
9. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Sung JJ; Chung SC; Yung MY; Lai CW; Lau JY; Lee YT; Leung VK; Li MK; Li AK Lancet; 1995 Dec 23-30; 346(8991-8992):1666-9. PubMed ID: 8551824 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study. Rengasamy S; Ali SM; Sistla SC; Lakshmi CP; Harichandra Kumar KT Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):386-92. PubMed ID: 25874510 [TBL] [Abstract][Full Text] [Related]
11. Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial. Morales GF; Pereira Lima JC; Hornos AP; Marques DL; Costa CS; Lima Pereira L; Lopes CV; Raymondi R; Marroni CA Hepatogastroenterology; 2007; 54(73):195-200. PubMed ID: 17419259 [TBL] [Abstract][Full Text] [Related]
12. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Avgerinos A; Nevens F; Raptis S; Fevery J Lancet; 1997 Nov; 350(9090):1495-9. PubMed ID: 9388396 [TBL] [Abstract][Full Text] [Related]
13. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Zuberi BF; Baloch Q Am J Gastroenterol; 2000 Mar; 95(3):768-71. PubMed ID: 10710072 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of five days of subcutaneous octreotide treatment after sclerotherapy in preventing rebleeding from esophageal varices. Yücesoy M; Başkol M; Keklik M; Güven M; Sungur M; Gürsoy S; Güven K; Ozbakir O Turk J Gastroenterol; 2004 Sep; 15(3):137-43. PubMed ID: 15492910 [TBL] [Abstract][Full Text] [Related]
15. Octreotide in acute bleeding esophageal varices: a prospective randomized study. Freitas DS; Sofia C; Pontes JM; Gregório C; Cabral JP; Andrade P; Rosa A; Camacho E; Ferreira M; Portela F; Romãozinho JM; Tomé L; Gouveia H; Leitão M; Pimenta I; Donato A Hepatogastroenterology; 2000; 47(35):1310-4. PubMed ID: 11100339 [TBL] [Abstract][Full Text] [Related]
16. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy. Ravi M; Kate V; Ananthakrishnan N Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957 [TBL] [Abstract][Full Text] [Related]
17. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Gimson AE; Ramage JK; Panos MZ; Hayllar K; Harrison PM; Williams R; Westaby D Lancet; 1993 Aug; 342(8868):391-4. PubMed ID: 8101900 [TBL] [Abstract][Full Text] [Related]